HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR

Isolated human monoclonal antibodies which bind to human TF and related antibody- based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. La presente invención se refie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TOM VINK, MAROESKA OUDSHOORN, DAVID P.E. SATIJN, SANDRA VERPLOEGEN, PAUL PARREN, VIBEKE MILLER BREINHOLT, ROB N. DE JONG, OLE BAADSGAARD, WILLEM KAREL BLEEKER, EVA EHRNROOTH, RENE M.A. HOET, MISCHA HOUTKAMP, JAN VAN DE WINKEL
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TOM VINK
MAROESKA OUDSHOORN
DAVID P.E. SATIJN
SANDRA VERPLOEGEN
PAUL PARREN
VIBEKE MILLER BREINHOLT
ROB N. DE JONG
OLE BAADSGAARD
WILLEM KAREL BLEEKER
EVA EHRNROOTH
RENE M.A. HOET
MISCHA HOUTKAMP
JAN VAN DE WINKEL
description Isolated human monoclonal antibodies which bind to human TF and related antibody- based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. La presente invención se refiere a un anticuerpo humano el cual une factor tisular (TF), caracterizado porque: compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la SEC ID NO: 9 y una región VL que comprende la secuencia de las SEC ID NO: 65, y no compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la secuencia de la SEC ID NO: 37 y una región VL que comprende la secuencia de la SEC ID NO: 93.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX338754B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX338754B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX338754B3</originalsourceid><addsrcrecordid>eNrjZNDxCPV19FNw9AvxdPJ38XQNVnB0d_T0Cw5RgEiEeAYHh7oquDk6h_gH8TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeN8IY2MLc1MTJ2OCCgDIUCQq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR</title><source>esp@cenet</source><creator>TOM VINK ; MAROESKA OUDSHOORN ; DAVID P.E. SATIJN ; SANDRA VERPLOEGEN ; PAUL PARREN ; VIBEKE MILLER BREINHOLT ; ROB N. DE JONG ; OLE BAADSGAARD ; WILLEM KAREL BLEEKER ; EVA EHRNROOTH ; RENE M.A. HOET ; MISCHA HOUTKAMP ; JAN VAN DE WINKEL</creator><creatorcontrib>TOM VINK ; MAROESKA OUDSHOORN ; DAVID P.E. SATIJN ; SANDRA VERPLOEGEN ; PAUL PARREN ; VIBEKE MILLER BREINHOLT ; ROB N. DE JONG ; OLE BAADSGAARD ; WILLEM KAREL BLEEKER ; EVA EHRNROOTH ; RENE M.A. HOET ; MISCHA HOUTKAMP ; JAN VAN DE WINKEL</creatorcontrib><description>Isolated human monoclonal antibodies which bind to human TF and related antibody- based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. La presente invención se refiere a un anticuerpo humano el cual une factor tisular (TF), caracterizado porque: compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la SEC ID NO: 9 y una región VL que comprende la secuencia de las SEC ID NO: 65, y no compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la secuencia de la SEC ID NO: 37 y una región VL que comprende la secuencia de la SEC ID NO: 93.</description><language>eng ; spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160429&amp;DB=EPODOC&amp;CC=MX&amp;NR=338754B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160429&amp;DB=EPODOC&amp;CC=MX&amp;NR=338754B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TOM VINK</creatorcontrib><creatorcontrib>MAROESKA OUDSHOORN</creatorcontrib><creatorcontrib>DAVID P.E. SATIJN</creatorcontrib><creatorcontrib>SANDRA VERPLOEGEN</creatorcontrib><creatorcontrib>PAUL PARREN</creatorcontrib><creatorcontrib>VIBEKE MILLER BREINHOLT</creatorcontrib><creatorcontrib>ROB N. DE JONG</creatorcontrib><creatorcontrib>OLE BAADSGAARD</creatorcontrib><creatorcontrib>WILLEM KAREL BLEEKER</creatorcontrib><creatorcontrib>EVA EHRNROOTH</creatorcontrib><creatorcontrib>RENE M.A. HOET</creatorcontrib><creatorcontrib>MISCHA HOUTKAMP</creatorcontrib><creatorcontrib>JAN VAN DE WINKEL</creatorcontrib><title>HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR</title><description>Isolated human monoclonal antibodies which bind to human TF and related antibody- based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. La presente invención se refiere a un anticuerpo humano el cual une factor tisular (TF), caracterizado porque: compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la SEC ID NO: 9 y una región VL que comprende la secuencia de las SEC ID NO: 65, y no compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la secuencia de la SEC ID NO: 37 y una región VL que comprende la secuencia de la SEC ID NO: 93.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDxCPV19FNw9AvxdPJ38XQNVnB0d_T0Cw5RgEiEeAYHh7oquDk6h_gH8TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeN8IY2MLc1MTJ2OCCgDIUCQq</recordid><startdate>20160429</startdate><enddate>20160429</enddate><creator>TOM VINK</creator><creator>MAROESKA OUDSHOORN</creator><creator>DAVID P.E. SATIJN</creator><creator>SANDRA VERPLOEGEN</creator><creator>PAUL PARREN</creator><creator>VIBEKE MILLER BREINHOLT</creator><creator>ROB N. DE JONG</creator><creator>OLE BAADSGAARD</creator><creator>WILLEM KAREL BLEEKER</creator><creator>EVA EHRNROOTH</creator><creator>RENE M.A. HOET</creator><creator>MISCHA HOUTKAMP</creator><creator>JAN VAN DE WINKEL</creator><scope>EVB</scope></search><sort><creationdate>20160429</creationdate><title>HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR</title><author>TOM VINK ; MAROESKA OUDSHOORN ; DAVID P.E. SATIJN ; SANDRA VERPLOEGEN ; PAUL PARREN ; VIBEKE MILLER BREINHOLT ; ROB N. DE JONG ; OLE BAADSGAARD ; WILLEM KAREL BLEEKER ; EVA EHRNROOTH ; RENE M.A. HOET ; MISCHA HOUTKAMP ; JAN VAN DE WINKEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX338754B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TOM VINK</creatorcontrib><creatorcontrib>MAROESKA OUDSHOORN</creatorcontrib><creatorcontrib>DAVID P.E. SATIJN</creatorcontrib><creatorcontrib>SANDRA VERPLOEGEN</creatorcontrib><creatorcontrib>PAUL PARREN</creatorcontrib><creatorcontrib>VIBEKE MILLER BREINHOLT</creatorcontrib><creatorcontrib>ROB N. DE JONG</creatorcontrib><creatorcontrib>OLE BAADSGAARD</creatorcontrib><creatorcontrib>WILLEM KAREL BLEEKER</creatorcontrib><creatorcontrib>EVA EHRNROOTH</creatorcontrib><creatorcontrib>RENE M.A. HOET</creatorcontrib><creatorcontrib>MISCHA HOUTKAMP</creatorcontrib><creatorcontrib>JAN VAN DE WINKEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TOM VINK</au><au>MAROESKA OUDSHOORN</au><au>DAVID P.E. SATIJN</au><au>SANDRA VERPLOEGEN</au><au>PAUL PARREN</au><au>VIBEKE MILLER BREINHOLT</au><au>ROB N. DE JONG</au><au>OLE BAADSGAARD</au><au>WILLEM KAREL BLEEKER</au><au>EVA EHRNROOTH</au><au>RENE M.A. HOET</au><au>MISCHA HOUTKAMP</au><au>JAN VAN DE WINKEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR</title><date>2016-04-29</date><risdate>2016</risdate><abstract>Isolated human monoclonal antibodies which bind to human TF and related antibody- based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. La presente invención se refiere a un anticuerpo humano el cual une factor tisular (TF), caracterizado porque: compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la SEC ID NO: 9 y una región VL que comprende la secuencia de las SEC ID NO: 65, y no compite por unión de TF con un anticuerpo de referencia que comprende una región VH que comprende la secuencia de la SEC ID NO: 37 y una región VL que comprende la secuencia de la SEC ID NO: 93.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX338754B
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HUMAN ANTIBODIES AGAINST HUMAN TISSUE FACTOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A41%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TOM%20VINK&rft.date=2016-04-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX338754B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true